Haleon launches Eroxon

Eroxon, an FDA cleared gel available without a prescription for the treatment of erectile dysfunction, is now available for pre-order in the United States through Amazon and will be available at most major retailers in October 2024.

Haleon said that Eroxon is clinically proven to help men get an erection within 10 minutes to foster physical intimacy (individual results may vary). The treatment stimulates nerve endings in the penis to help men with ED get and maintain an erection during sex. Given existing prescription solutions may take up to an hour to work (based on labels), Eroxon addresses a significant unmet need for men experiencing ED, Haleon said.

[Read more: How the sexual wellness category is benefiting from innovation and increased shelf space]

Lisa Paley, president, North America at Haleon, said, "At Haleon, we have a clear purpose to deliver better everyday health with humanity. Introducing Eroxon to U.S. consumers reflects our belief that sexual health is a critical part of wellness. We understand how important making meaningful and intimate connections are to one's wellbeing, and Eroxon helps achieve just that. We are proud to take this bold step to make this first-of-its-kind over-the-counter (OTC) gel treatment accessible to the millions of men in the U.S. who are affected by ED."

[Read more: Haleon selects Collectively as influencer, marketing partner]

Gerald Brock, Haleon partner, said, "The body of scientific evidence for Eroxon supports it as an effective, fast-acting, and accessible OTC ED treatment with an excellent safety profile."